| scholarly article | Q13442814 |
| P50 | author | Marla Gearing | Q67212581 |
| Madhav Thambisetty | Q71775824 | ||
| P2093 | author name string | Allan I Levey | |
| Duc M Duong | |||
| Nicholas T Seyfried | |||
| Eric B Dammer | |||
| James J Lah | |||
| Juan C Troncoso | |||
| Joshua M Shulman | |||
| Chadwick M Hales | |||
| Qiudong Deng | |||
| P2860 | cites work | Membrane-anchored Aβ accelerates amyloid formation and exacerbates amyloid-associated toxicity in mice. | Q46963608 |
| ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease | Q47754186 | ||
| Expression of regulatory proteins in choroid plexus changes in early stages of Alzheimer disease | Q48288518 | ||
| Loss of PAFAH1B2 reduces amyloid-β generation by promoting the degradation of amyloid precursor protein C-terminal fragments. | Q51843744 | ||
| Complement activation in amyloid plaques in Alzheimer's dementia. | Q53187583 | ||
| Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. | Q54613756 | ||
| Apolipoprotein E Interaction with the Neurofibrillary Tangles and Senile Plaques in Alzheimer Disease: Implications for Disease Pathogenesis | Q72108189 | ||
| Cytoscape: a software environment for integrated models of biomolecular interaction networks | Q24515682 | ||
| Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis | Q24562844 | ||
| Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q24595802 | ||
| Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS | Q24629495 | ||
| Roles of 17β-hydroxysteroid dehydrogenase type 10 in neurodegenerative disorders | Q26994687 | ||
| Neuropathological alterations in Alzheimer disease | Q27003314 | ||
| Neuropathological stageing of Alzheimer-related changes | Q27860862 | ||
| The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics | Q27860914 | ||
| Proteomics of protein post-translational modifications implicated in neurodegeneration | Q28088631 | ||
| Adapting proteostasis for disease intervention | Q28131818 | ||
| Protein aggregation and neurodegenerative disease | Q28273600 | ||
| The SMN complex: an assembly machine for RNPs | Q28294580 | ||
| Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization | Q28588090 | ||
| Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry | Q29547311 | ||
| The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease | Q29614948 | ||
| The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics | Q29614972 | ||
| Amyloid deposition as the central event in the aetiology of Alzheimer's disease | Q29619450 | ||
| Immunophilin FKBP52 induces Tau-P301L filamentous assembly in vitro and modulates its activity in a model of tauopathy | Q30574960 | ||
| Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition | Q30800087 | ||
| U1 small nuclear ribonucleoproteins (snRNPs) aggregate in Alzheimer's disease due to autosomal dominant genetic mutations and trisomy 21. | Q33616573 | ||
| Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer's disease. | Q33745920 | ||
| Aggregates of small nuclear ribonucleic acids (snRNAs) in Alzheimer's disease. | Q33894846 | ||
| An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. | Q34123789 | ||
| Toxic proteins in neurodegenerative disease | Q34133493 | ||
| Coaggregation of RNA-binding proteins in a model of TDP-43 proteinopathy with selective RGG motif methylation and a role for RRM1 ubiquitination | Q34285952 | ||
| Neuropathologic studies of the Baltimore Longitudinal Study of Aging (BLSA) | Q34298372 | ||
| Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease. | Q34473854 | ||
| Interaction of tau with the RNA-Binding Protein TIA1 Regulates tau Pathophysiology and Toxicity | Q34525808 | ||
| Aggregation properties of the small nuclear ribonucleoprotein U1-70K in Alzheimer disease | Q34737880 | ||
| Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins. | Q35498406 | ||
| A yeast functional screen predicts new candidate ALS disease genes | Q35641365 | ||
| Analysis of a membrane-enriched proteome from postmortem human brain tissue in Alzheimer's disease. | Q35917235 | ||
| Quantitative analysis of the detergent-insoluble brain proteome in frontotemporal lobar degeneration using SILAC internal standards | Q35975425 | ||
| GO-Elite: a flexible solution for pathway and ontology over-representation | Q36145842 | ||
| ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function | Q36320469 | ||
| Evaluation of annexin A5 as a biomarker for Alzheimer's disease and dementia with lewy bodies | Q36742691 | ||
| The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals | Q37090083 | ||
| Asparaginyl endopeptidase cleaves TDP-43 in brain | Q37208989 | ||
| U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease | Q37236333 | ||
| Complement and microglia mediate early synapse loss in Alzheimer mouse models. | Q37391481 | ||
| Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer's disease | Q37442587 | ||
| Functional screening in Drosophila identifies Alzheimer's disease susceptibility genes and implicates Tau-mediated mechanisms | Q37508556 | ||
| The different functions of Norrin. | Q37969975 | ||
| Tau pathology and neurodegeneration | Q38107632 | ||
| Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies | Q38841875 | ||
| Association of frailty with the serine protease HtrA1 in older adults. | Q38883957 | ||
| Characterization and molecular profiling of PSEN1 familial Alzheimer's disease iPSC-derived neural progenitors | Q39035111 | ||
| Alzheimer's Aβ interacts with cellular prion protein inducing neuronal membrane damage and synaptotoxicity | Q39054487 | ||
| Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease | Q40573179 | ||
| Impaired retrograde transport by the Dynein/Dynactin complex contributes to Tau-induced toxicity | Q41186950 | ||
| Systematical optimization of reverse-phase chromatography for shotgun proteomics | Q42068281 | ||
| Human high temperature requirement serine protease A1 (HTRA1) degrades tau protein aggregates | Q42201998 | ||
| Fast R Functions for Robust Correlations and Hierarchical Clustering | Q42239626 | ||
| Neuron enriched nuclear proteome isolated from human brain. | Q42539702 | ||
| Serum amyloid P immunoreactivity in hippocampal tangles, plaques and vessels: implications for leakage across the blood-brain barrier in Alzheimer's disease | Q43457313 | ||
| Progressive infantile neurodegeneration caused by 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency: a novel inborn error of branched-chain fatty acid and isoleucine metabolism | Q43511079 | ||
| Ribosome dysfunction is an early event in Alzheimer's disease. | Q46738279 | ||
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| ggplot2 | Q326489 | ||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 3042-3053 | |
| P577 | publication date | 2016-10-08 | |
| P1433 | published in | Proteomics | Q15614164 |
| P1476 | title | Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression | |
| P478 | volume | 16 |
| Q90146931 | Aberrant accrual of BIN1 near Alzheimer's disease amyloid deposits in transgenic models |
| Q91045286 | Ageing and amyloidosis underlie the molecular and pathological alterations of tau in a mouse model of familial Alzheimer's disease |
| Q64949212 | Changes in proteome solubility indicate widespread proteostatic disruption in mouse models of neurodegenerative disease. |
| Q47395290 | Characterization of Detergent Insoluble Proteome in Chronic Traumatic Encephalopathy. |
| Q93047281 | Deep Profiling of the Aggregated Proteome in Alzheimer's Disease: From Pathology to Disease Mechanisms |
| Q57029721 | Deep proteomic network analysis of Alzheimer's disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease |
| Q47351811 | Detergent Insoluble Proteins and Inclusion Body-Like Structures Immunoreactive for PRKDC/DNA-PK/DNA-PKcs, FTL, NNT, and AIFM1 in the Amygdala of Cognitively Impaired Elderly Persons. |
| Q98939496 | Development and validation of a six-RNA binding proteins prognostic signature and candidate drugs for prostate cancer |
| Q47384845 | Enrichment of Detergent-insoluble Protein Aggregates from Human Postmortem Brain |
| Q92387684 | Identification of molecular signatures and pathways to identify novel therapeutic targets in Alzheimer's disease: Insights from a systems biomedicine perspective |
| Q50420333 | Interactome Analysis Reveals Regulator of G Protein Signaling 14 (RGS14) is a Novel Calcium/Calmodulin (Ca2+/CaM) and CaM Kinase II (CaMKII) Binding Partner. |
| Q88867119 | RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease |
| Q99212853 | Systems-based proteomics to resolve the biology of Alzheimer's disease beyond amyloid and tau |
Search more.